Trial Condition(s):

Neoplastic CNS lesions

Contrast Enhanced MRI of the CNS - Patients with known cerebral neoplastic lesions.

Bayer Identifier:

91780

ClinicalTrials.gov Identifier:

NCT00764387

EudraCT Number:

2007-005693-31

Study Completed

Trial Purpose

Study to compare of two contrast agents in imaging brain lesions.

Inclusion Criteria
: 
 - Known neoplastic CNS lesions
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
166
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Gadavist/Gadovist (Gadobutrol, BAY86-4875)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Novara, Italy, 28100

Status
Completed
 
Locations

Investigative Site

Verona, Italy, 37126

Status
Completed
 
Locations

Investigative Site

Napoli, Italy, 80131

Status
Completed
 
Locations

Investigative Site

Trieste, Italy, 34149

Status
Completed
 
Locations

Investigative Site

Barletta-Andria-Trani, Italy, 70031

Status
Completed
 
Locations

Investigative Site

Milano, Italy, 20132

Status
Completed
 
Locations

Investigative Site

Roma, Italy, 00168

Status
Completed
 
Locations

Investigative Site

Chieti, Italy, 66100

Status
Completed
 
Locations

Investigative Site

Catania, Italy, 95126

Status
Completed
 
Locations

Investigative Site

Messina, Italy, 98125

Status
Completed
 
Locations

Investigative Site

Siena, Italy, 53100

Status
Completed
 
Locations

Investigative Site

Roma, Italy, 00133

Status
Completed
 

Trial Design